Regular Article
Osteoporosis in men

https://doi.org/10.1053/berh.2001.0158Get rights and content

Abstract

Osteoporosis is characterized by a reduction in bone density, associated with skeletal fragility and an increased risk of fracture after minimal trauma. Although osteoporosis is generally considered to be a condition affecting post-menopausal women, it is now clear that substantial bone loss occurs with advancing age in men, such that up to 20% of symptomatic vertebral fractures and 30% of hip fractures occur in men. This chapter highlights the incidence and prevalence of osteoporotic fractures in men and reviews the associated morbidity, excess mortality and health and social service expenditure. The determinants of peak bone mass and bone loss in men are discussed, as is the pathogenesis of osteoporosis and vertebral and hip fractures. The criteria for the diagnosis of osteoporosis in men are reviewed, together with the most appropriate investigations for secondary osteoporosis. The management of osteoporosis in men is also discussed, highlighting the most appropriate treatment options.

References (51)

  • RM Francis et al.

    Spinal osteoporosis in men

    Bone and Mineral

    (1989)
  • E Seeman et al.

    Risk factors for spinal osteoporosis in men

    American Journal of Medicine

    (1983)
  • RM Francis et al.

    Osteoporosis in hypogonadal men: role of decreased plasma 1,25 dihydroxyvitamin D, calcium malabsorption and low bone formation

    Bone

    (1986)
  • R Eastell et al.

    Management of male osteoporosis: report of the UK Consensus Group

    Quarterly Journal of Medicine

    (1998)
  • SR Cummings et al.

    Lifetime risks of hip, Colles', or vertebral fracture and coronary heart disease among white postmenopausal women

    Archives of Internal Medicine

    (1989)
  • O Johnell et al.

    The apparent incidence of hip fracture in Europe: a study of national register sources. MEDOS Study Group

    Osteoporosis International

    (1992)
  • I Pande

    Causes and consequences of hip fracture in men.

    (2000)
  • G Poor et al.

    Age-related hip fracture in men: clinical spectrum and short-term outcome

    Osteoporosis International

    (1995)
  • TW O'Neill et al.

    The prevalence of vertebral deformity in European men and women. The European Vertebral Osteoporosis Study

    Journal of Bone and Mineral Research

    (1996)
  • KM Davies et al.

    Prevalence and severity of vertebral fracture: the Saunders County Bone Quality Study

    Osteoporosis International

    (1996)
  • AA Ismail et al.

    Risk factors for vertebral deformities in men: relationship to number of vertebral deformities

    Journal of Bone and Mineral Research

    (2000)
  • AC Scane et al.

    Case-control study of the pathogenesis and sequelae of symptomatic vertebral fractures in men

    Osteoporosis International

    (1999)
  • SB Soroko et al.

    Family history of osteoporosis and bone mineral density at the axial skeleton: the Rancho Bernardo study

    Journal of Bone and Mineral Research

    (1994)
  • AC Scane et al.

    Risk factors for osteoporosis in men

    Clinical Endocrinology

    (1993)
  • E Seeman

    Osteoporosis in men

    Osteoporosis International

    (1999)
  • BL Riggs et al.

    A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis and contributes to bone loss in ageing men

    Journal of Bone and Mineral Research

    (1998)
  • C Slemenda et al.

    Sex steroids and bone mass in older men. Positive associations with serum estrogen, and negative associations with androgens

    Journal of Clinical Investigation

    (1997)
  • TV Nguyen et al.

    Risk factors for osteoporotic fractures in elderly men

    American Journal of Epidemiology

    (1996)
  • C ED De Laet et al.

    Bone density and risk of hip fracture in men and women: cross-sectional analysis

    British Medical Journal

    (1997)
  • I Pande et al.

    Bone mineral density, hip axis length and risk of hip fracture in men: results from the Cornwall Hip Fracture Study

    Osteoporosis International

    (2000)
  • G Poor et al.

    Predictors of hip fractures in elderly men

    Journal of Bone and Mineral Research

    (1995)
  • JA Grisso et al.

    Risk factors for hip fracture in men. Hip Fracture Study Group

    American Journal of Epidemiology

    (1997)
  • ME Mussolino et al.

    Risk factors for hip fracture in white men: the NHANES I Epidemiologic Follow-up Study

    Journal of Bone and Mineral Research

    (1998)
  • MR Law et al.

    A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect

    British Medical Journal

    (1997)
  • C Cooper et al.

    Physical activity, muscle strength, and calcium intake in fracture of the proximal femur in Britain

    British Medical Journal

    (1988)
  • Cited by (31)

    • Trabecular Bone Score in obese, overweight and normal-weight young men

      2017, Science and Sports
      Citation Excerpt :

      Although osteoporosis is known to mainly affect postmenopausal women, there is enough evidence to support substantial loss of bone strength with aging in men as well [1–3].

    • Impact of Pueraria candollei var. mirifica and its potent phytoestrogen miroestrol on expression of bone-specific genes in ovariectomized mice

      2012, Fitoterapia
      Citation Excerpt :

      In addition, a very recent study demonstrated that PME and its isoflavone, puerarin, possibly enhanced bone formation by promoting osteoblast differentiation via up-regulation of ALP mRNA expression and an increase of the ratio of OPG to RANKL [10]. As the prevalence of osteoporosis in woman is generally two to three times higher than that similarly age men, estrogen deficiency has been recognized as a key factor of osteoporosis development [11]. Miroestrol (MR) is a phytoestrogen in tuberous roots of PM (Fig. 1) [12].

    • Male osteoporosis

      2007, Seminarios de la Fundacion Espanola de Reumatologia
    View all citing articles on Scopus
    f1

    Author to whom all correspondence should be addressed.

    View full text